155 related articles for article (PubMed ID: 36458570)
1. Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
Le Cras R; Mazet R; Dubois-Teklali F; Sabourdy C; Chanoine S; Lehmann A; Morin A; Leenhardt J; Durand M; Desruet MD; Bedouch P
Emerg Microbes Infect; 2023 Dec; 12(1):2148563. PubMed ID: 36458570
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
Dyken PR; Swift A; DuRant RH
Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
[TBL] [Abstract][Full Text] [Related]
3. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study.
Gascon GG;
J Child Neurol; 2003 Dec; 18(12):819-27. PubMed ID: 14736075
[TBL] [Abstract][Full Text] [Related]
4. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
DuRant RH; Dyken PR; Swift AV
J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
[TBL] [Abstract][Full Text] [Related]
5. The effect of inosiplex on the survival of subacute sclerosing panencephalitis.
DuRant RH; Dyken PR
Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362
[TBL] [Abstract][Full Text] [Related]
6. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
[TBL] [Abstract][Full Text] [Related]
7. [Therapy and prognosis in subacute sclerosing panencephalitis].
Hosoya M
Nihon Rinsho; 2007 Aug; 65(8):1483-6. PubMed ID: 17695288
[TBL] [Abstract][Full Text] [Related]
8. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
Nihei K; Kudo H; Abe T; Naito H; Suzuki S; Miyao M
No To Hattatsu; 1984 Jul; 16(4):262-70. PubMed ID: 6207848
[No Abstract] [Full Text] [Related]
9. Treatment of subacute sclerosing panencephalitis: an overview.
Taylor WJ; DuRant RH; Dyken PR
Drug Intell Clin Pharm; 1984 May; 18(5):375-81. PubMed ID: 6202474
[TBL] [Abstract][Full Text] [Related]
10. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.
Jones CE; Dyken PR; Huttenlocher PR; Jabbour JT; Maxwell KW
Lancet; 1982 May; 1(8280):1034-7. PubMed ID: 6176821
[TBL] [Abstract][Full Text] [Related]
11. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report.
Han CY; Lin HF; Shin PY; Liu CK; Liu CS
Kaohsiung J Med Sci; 2003 Aug; 19(8):416-20. PubMed ID: 12962429
[TBL] [Abstract][Full Text] [Related]
12. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis.
Yalaz K; Anlar B; Oktem F; Aysun S; Ustacelebi S; Gurcay O; Gucuyener K; Renda Y
Neurology; 1992 Mar; 42(3 Pt 1):488-91. PubMed ID: 1372397
[TBL] [Abstract][Full Text] [Related]
13. Inosiplex in the treatment of subacute sclerosing panencephalitis.
Silverberg R; Brenner T; Abramsky O
Arch Neurol; 1979 Jun; 36(6):374-5. PubMed ID: 88215
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
[TBL] [Abstract][Full Text] [Related]
15. [Anti SSPE drugs].
Hosoya M
Nihon Rinsho; 2012 Apr; 70(4):625-8. PubMed ID: 22568144
[TBL] [Abstract][Full Text] [Related]
16. Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment.
Gupta E; Dar L; Singh S; Behari M; Broor S
Indian J Med Microbiol; 2006 Apr; 24(2):131-2. PubMed ID: 16687866
[TBL] [Abstract][Full Text] [Related]
17. Improvement of SSPE by intrathecal infusion of alpha-IFN.
Kurata T; Matsubara E; Yokoyama M; Nagano I; Shoji M; Abe K
Neurology; 2004 Jul; 63(2):398-9. PubMed ID: 15277654
[No Abstract] [Full Text] [Related]
18. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study.
Anlar B; Yalaz K; Imir T; Turanli G
Eur Neurol; 1994; 34(1):44-7. PubMed ID: 7511102
[TBL] [Abstract][Full Text] [Related]
19. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
Haddad FS; Risk WS
Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
[TBL] [Abstract][Full Text] [Related]
20. Inosiplex for SSPE.
Jones C
Lancet; 1982 Aug; 2(8296):495. PubMed ID: 6180266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
